Tag: Syfovre

Izervay: FDA Approved Breakthrough for Geographic Atrophy
Posted on September 21, 2023 by Austin Retina Associates
Categories: Retina Treatments
For the estimated 11 million Americans living with age-related macular degeneration (AMD), geographic atrophy (GA) can be a daunting reality. Approximately 20% of patients with AMD will develop geographic atrophy, an advanced form of dry AMD characterized by the progressive loss of healthy retinal …
Read More

Delivering excellence in retina care while treating everyone with respect and dignity.